In this video, Michael Cecchini, MD, discusses “practice-changing” data from the CheckMate 8HW study, which were presented at ASCO Gastrointestinal Cancers Symposium.

While uncertainty remains in the market, periods of heightened volatility often create compelling opportunities for ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.

Bristol Myers Squibb, a global biopharmaceutical company, has appointed Osama Braiwish as its General Manager for Saudi ...

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons ...

Pfizer stock has delivered its long-term shareholders a dividend that has grown for 16 consecutive years. The pace of those ...

Bristol-Myers Squibb (BMY) stands out as one of the most undervalued biotech stocks, backed by strong financials and a robust ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

The March 19 edition of the SBJ Tech newsletter features a chat with NCAA VP, Chief Technology Officer John Macrina on his ...